Superior efficacy and similar safety of double dose anakinra in Erdheim-Chester disease after single dose treatment

Objectives. In Erdheim-Chester disease (ECD), the empirical single dose (SD, 100 mg/day) anakinra sometimes induces only partial responses. Since SD is usually well tolerated, doubling the dose might improve response while maintaining an acceptable safety profile. Methods. A retrospective analysis w...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncoimmunology
Main Authors: Franconieri, Fréderic, Deshayes, Samuel, de Boysson, Hubert, Trad, Salim, Martin Silva, Nicolas, Terrier, Benjamin, Bienvenu, Boris, Galateau-Sallé, Françoise, Emile, Jean-François, Johnson, Alison C., Aouba, Achille
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2018
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6136854/
https://ncbi.nlm.nih.gov/pubmed/30221042
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2018.1450712
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados